Disclosed is the use of a composition comprising about 5 parts inactivated polio vaccine ("IPV") and about 2 parts of a bacterial antigen activator selected from the group consisting of tetanus toxoid, typhim VI, diphtheria toxoid and mixtures thereof in the manufacture of a medicament for treating, ameliorating or abating pain symptoms which result from rheumatoid arthritis, memory loss and cognitive impairment symptoms which result from Alzheimer's Disease and tremor and bradykinesa symptoms which result from Parkinson's Disease.
